Kopran Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: KOPRAN BSE: 524280
₹278.32
▼ -12.58 (-4.32%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
67/100
Moderate
Valuation
51/100
Fairly Valued
Momentum
88/100
Bullish

QVM read Momentum-led Quality Moderate, Valuation Fairly Valued, Momentum Bullish

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹1,344 Cr
PE (TTM)
40.0
Industry median 36.1 (152 companies)
Price to Book
2.5
PEG (TTM)
1.4
Institutions holding %
0.51%
FII + DII, latest filed period
Piotroski Score
7
Relative return vs Nifty50, qtr %
57.0
Relative return vs Sector, qtr %
47.5
Free Cash Flow
₹8 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
90.41%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
67.13%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
16.25%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
91.10%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
22.25%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.51
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.29
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
11.14
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
10.71%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
15.97%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
15.44%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
2.83%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
7.97%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
4.85%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

3 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Piotroski F-score is 7 or more (score 7)
  • Yes Debt to equity is below 0.5 (0.29)
  • No Return on equity is 15% or more (4.9%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

3 of 4 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

3 of 3 met
  • Yes 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

2 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Fair Value Zone)
  • No Valuation score is Undervalued (70 or more)
  • Yes Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-4.3%
Low 277.0100 · High 295.8300
1W return
-0.4%
Low 267.3000 · High 295.8300
1M return
27.8%
Low 214.0000 · High 295.8300
52W return
58.5%
Low 107.0000 · High 295.8300
Lifetime High ₹543.0000 (Dec. 1, 1994)
Lifetime Low ₹6.8000 (March 12, 2009)

Full price history and technicals →

EMA & SMA

Bullish5
Bearish1
5D
280.6
10D
274.6
20D
259.6
50D
231.4
100D
207.6
200D
170.5

Delivery and volume

Day avg. delivery
33.5%
Week avg. delivery
38.2%
Month avg. delivery
19.5%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

283.72
Pivot
First resistance290.43
Second resistance302.54
Third resistance309.25
First support271.61
Second support264.90
Third support252.79
Day RSI64.0
Day MFI95.5
Day MACD19.54
Day MACD signal18.90

Beta

1M2.06
3M0.71
1Y1.40
3Y1.42

Price change analysis

↑ 27.8%
Over 1 Month
LowHigh
214.00295.83
↑ 47.5%
Over 3 Months
LowHigh
166.00295.83
↑ 134.3%
Over 6 Months
LowHigh
113.16295.83
↑ 58.5%
Over 1 Year
LowHigh
107.00295.83
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 40.0 (own history: 17.2–54.1)
Fair Value Zone
Revenue (June 30, 2026)
₹63 Cr
Net profit (June 30, 2026)
₹7 Cr
Basic EPS (June 30, 2026)
₹1.3900

Ranks #86 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter44.42%
  • FII/FPI0.51%
  • Public55.07%

Largest holders

NameCategoryShares %Shares
ORICON ENTERPRISES LIMITEDPromoter12.8800%6217183
PANORAMA FINVEST PVT LTDPromoter7.8700%3800000
SARVAMANGAL MERCANTILE CO LTDPromoter6.0100%2902951
UNITED SHIPPERS LTDPromoter4.5600%2200000
ORIENTAL ENTERPRISES (SURENDRA SOMANI)Promoter3.6500%1764750

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 44.42% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 0.57% to 0.51% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings were unchanged at 0.00% in Jun 2026 qtr

All shareholding details →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
8 Jan 2025 Mridula Somani Promoter group Buy 0 ₹0
20 Dec 2024 Mridula Somani Promoter group Buy 0 ₹0
5 Jun 2023 Mridula Somani Promoter group Buy 0 ₹0
3 Apr 2023 Surendra Somani Promoter Buy 0 ₹0
3 Apr 2023 Surendra Somani Promoter Buy 0 ₹0
30 Jan 2023 Mridula Somani Promoter group Buy 0 ₹0
22 Nov 2022 HAZARIMALL SOMANI Promoter group Buy 0 ₹0
17 Nov 2022 HAZARIMALL SOMANI Promoter group Buy 0 ₹0
20 Apr 2018 Oricon Enterprises Limited Promoter group Buy 0 ₹0
9 May 2016 Oricon Properties Private Limited Promoter Buy 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
17 Sep 2026 QE SECURITIES LLP Bulk Sell 257,185 265.5900 NSE
17 Sep 2026 QE SECURITIES LLP Bulk Buy 250,015 265.8800 NSE
16 Sep 2026 QE SECURITIES LLP Bulk Buy 562,128 260.9200 NSE
16 Sep 2026 QE SECURITIES LLP Bulk Sell 573,173 261.6200 NSE
16 Sep 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Sell 389,295 265.6900 NSE
16 Sep 2026 NK SECURITIES RESEARCH PRIVATE LIMITED Bulk Buy 389,295 265.5600 NSE
16 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Sell 674,213 265.7600 NSE
16 Sep 2026 MICROCURVES TRADING PRIVATE LIMITED Bulk Buy 674,213 265.5400 NSE
16 Sep 2026 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Sell 597,857 262.8900 NSE
16 Sep 2026 JUNOMONETA FINSOL PRIVATE LIMITED Bulk Buy 600,758 262.8600 NSE

All bulk and block deals →

Last 12 months ₹3.00 per share
Dividend yield 1.08%
Ex-dateSubjectPer share (₹)Record date
11 Aug 2026 Dividend - Rs 3 Per Share 3.0000 11 Aug 2026
4 Sep 2025 Dividend - Rs 3 Per Share 3.0000 4 Sep 2025
2 Sep 2024 Annual General Meeting/Dividend - Rs 3 Per Share 3.0000 —
7 Sep 2023 Annual General Meeting/Dividend - Rs 3 Per Share 3.0000 —
4 Aug 2022 Dividend - Rs 3 Per Share 3.0000 —
5 Aug 2021 Dividend - Rs 1.50 Per Share 1.5000 —
5 Nov 2020 Interim Dividend - Rs 1.50 Per Share 1.5000 7 Nov 2020

Corporate Actions

Full history (23 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
3 Sep 2020OTHER Annual General Meeting
8 Jul 2019OTHER Annual General Meeting
27 Aug 2018OTHER Annual General Meeting
29 Aug 2017OTHER Annual General Meeting
6 Sep 2016OTHER Annual General Meeting

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
7 Aug 2026 Financial Results Yes
19 May 2026 Financial Results/Dividend Yes
22 Jan 2026 Financial Results Yes
12 Nov 2025 Financial Results Yes
29 Jul 2025 Financial Results Yes

Corporate Announcements

All 530 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
1 Oct 2026 Insider Trading / SAST Kopran Ltd - 524280 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
25 Sep 2026 Trading Window Kopran Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
25 Sep 2026 Insider Trading / SAST Kopran Ltd - 524280 - Closure of Trading Window
22 Sep 2026 Price movement Significant movement in price has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Kopran Limited has submitted their response.
21 Sep 2026 Price movement Significant movement in price has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, has written to the company. The response from the company is awaited.
21 Sep 2026 Company Update Kopran Ltd - 524280 - Clarification sought from Kopran Ltd
16 Sep 2026 Company Update Kopran Ltd - 524280 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
16 Sep 2026 ESOP/ESOS/ESPS Kopran Limited has informed the Exchange regarding Allotment of 40500 Shares.
8 Sep 2026 Insider Trading / SAST Kopran Ltd - 524280 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
1 Sep 2026 Spurt in Volume Significant increase in volume has been observed in Kopran Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Kopran Limited has submitted their response.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.29)
  • Comfortable interest coverage (11.1x)
  • Healthy liquidity (Current Ratio 1.51)
  • Strong revenue growth YoY (22.3%)

Weaknesses

  • Low Return on Equity (4.9%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (40.0) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Kopran Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.